key: cord-0879691-mwzhav4m
authors: Mariano, Rachel Zerbini; Pereira, Monica Corso; Reis, Fabiano
title: Hereditary hemorrhagic telangiectasia and COVID-19
date: 2020-11-25
journal: Revista da Sociedade Brasileira de Medicina Tropical
DOI: 10.1590/0037-8682-0785-2020
sha: 20b0d683b7591649e7643ed103268a887ea8e9fe
doc_id: 879691
cord_uid: mwzhav4m

nan

A 65-year-old woman with hereditary hemorrhagic telangiectasia (HHT) for which she was on home oxygen therapy without medication intake, was admitted to our emergency department for fever and worsening dyspnea. Her oxygen saturation on admission was 90%, akin to that at baseline. A Chest computed tomography (CT) scan revealed peripheral consolidations ( Figure 1A ) and enlarged feeding arteries, nodules, and draining veins (Figures 1B and 1C) ; nonetheless, a CT scan performed 1 month earlier showed no consolidations ( Figure 1D ). Real-time polymerase chain reaction confirmed SARS-CoV-2 infection. Despite early hospitalization and oxygen therapy by catheter and orotracheal intubation, the patient showed a progressive worsening of the respiratory function, developed a brain abscess (Figure 1E) , and died 26 days following admission.

HHT is an autosomal dominant disease, and the diagnostic criteria are the presence of epistaxis, multiple telangiectasias on mucocutaneous surfaces, arteriovenous malformations (AVMs) in larger organs, and a family history of the disease 1,2 . Oxygenation is commonly affected in patients with HHT 1,2 , and the frequent manipulation of the nostrils, nasal cavity, or nasopharynx may predispose them to contracting Coronavirus Disease 2019 (COVID-19) 3 . Moreover, patients with HHT have comorbidities that may negatively influence COVID-19 outcome, such as chronic

Osler-Weber-Rendu syndrome simulating pulmonary metastasis

European Reference Network For Rare Vascular Diseases (VASCERN) outcome measures for hereditary haemorrhagic telangiectasia (HHT)

Hereditary haemorrhagic telangiectasia: a disease not to be forgotten during the COVID-19 pandemic

We offer our deepest thanks to the institutions that provided technical support for the development and implementation of this study.

RZM: Conception and design of the study, Acquisition of data; MCP: Conception and design of the study, Analysis and interpretation of data, Final approval of the version to be submitted; FR: Conception and design of the study, Acquisition of data, Drafting the article, Final approval of the version to be submitted.

The authors declare that there is no conflict of interest.